Mithros Bioscience

Orem, United States Founded: 2017 • Age: 9 yrs
Develops anti-venom antibodies for medical applications.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Mithros Bioscience

Mithros Bioscience is a company based in Orem (United States) founded in 2017 by Jacob Glanville and Tim Friedel. It operates as a B2B. Mithros Bioscience operates in a competitive market with competitors including Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.

  • Headquarter Orem, United States
  • Founders Jacob Glanville, Tim Friedel
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Mithros Bioscience

Premium access

Detailed funding history for Mithros Bioscience

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Mithros Bioscience

Investments
Premium access

Investment portfolio details for Mithros Bioscience

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Mithros Bioscience

Premium access

Detailed financials for Mithros Bioscience

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Mithros Bioscience Comparisons

Mithros Bioscience Primary company
Description
Develops anti-venom antibodies for medical applications.
Location
Orem, United States
Founded Year
2017
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Mithros Bioscience

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Mithros Bioscience

Mithros Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Therapies for neurodegenerative and immunology disorders are developed.
Locked Locked Locked
Plasma-based biologics are developed for immune deficiency and infectious diseases.
Locked Locked Locked
Small molecule protein degraders are developed for various disorders.
Locked Locked Locked
Immunotherapeutics for cancer and other diseases are developed.
Locked Locked Locked
Developer of novel protein-based therapeutics using machine learning and biological engineering
Locked Locked Locked
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
Premium access

Detailed competitors of Mithros Bioscience

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Mithros Bioscience

Premium access

Complete news archive for Mithros Bioscience

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mithros Bioscience

Mithros Bioscience was founded in 2017.

Mithros Bioscience is headquartered in Orem, United States. It is registered at Orem, Utah, United States.

Mithros Bioscience, based in Orem, focuses on providing healthcare solutions, advancing biotech innovations, producing pharmaceutical products, and antibody development. Develops anti-venom antibodies for medical applications. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Mithros Bioscience's top competitors include ADMA Biologics, BioNTech and Vera Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available